SENSEX NIFTY
Ranbaxy Laboratories

News from other websites on Ranbaxy Laboratories

Ipca halts drug exports to US

Jul 25, 2014 at 08:12 | Source: Calcutta Telegraph News

Mumbai, July 24: Ipca Laboratories today said it was voluntarily suspending shipments of drug ingredients from one of its plants in the country, following concerns expressed by the US Food and Drug Administration (FDA). The mid-sized company said th...

Sun Pharma pops buyout pill again

Jul 17, 2014 at 03:47 | Source: Calcutta Telegraph News

Mumbai, July 16: After a blockbuster deal to acquire Ranbaxy Laboratories, Sun Pharma today announced that it was buying US-based Pharmalucence Inc for an undisclosed amount. Pharmalucence, which has sterile injectable capacity in the US, has been a...

India supplies pharma to 200 countries; but heavily dependent itself on imports from China: ASSOCHAM Study

Jul 04, 2014 at 20:17 | Source: Assocham

Alongside India building an unenviable reputation of being the pharmacy of the world supplying reliable and affordable medicines to over 200 countries, lesser known fact is that the country has become heavily import dependent on China when it comes ...

US booster dose for Ranbaxy

Jun 28, 2014 at 12:37 | Source: Calcutta Telegraph News

Mumbai, June 27: Ranbaxy Laboratories, which has been facing regulatory hurdles in the US, has been allowed to sell Valsartan tablets in the American market. Valsartan is the generic version of Novartis’s Diovan, a highly successful drug with ...

Infosys launches solution to tap clinical trial market

Jun 05, 2014 at 05:47 | Source: Economic Times

NEW DELHI: The country's second largest software services firm Infosys today launched a cloud-based version of its clinical trial supply management solution (CTSM) that will offer pharmaceutical firms reduced cost and faster time to market the new d...

Sun Pharma Q4 net profit up 57%

May 29, 2014 at 20:22 | Source: Economic Times

Sun Pharmaceutical Industries Ltd , India's third-largest drugmaker by revenue, on Thursday reported a 57 percent jump in fourth-quarter net profit, slightly above expectations, helped by higher sales in the United States, its largest market. The com...

Sun Pharma Q4 PAT surges 56.8 per cent to Rs 1587 crore

May 29, 2014 at 20:22 | Source: Economic Times

MUMBAI: Sun Pharmaceutical Industries, which is in the process of acquiring rival drug maker Ranbaxy Laboratories, posted a better-than-expected 57% jump in fourth-quarter net profit, as sales continued to grow at a healthy pace in the key US market...

Decide on Ranbaxy-Sun Pharma merger in 2 days: SC to Andhra HC

May 21, 2014 at 14:46 | Source: FirstPost

New Delhi: The Supreme Court today asked the Andhra Pradesh High Court, which had passed an interim order staying the $4 billion merger of Ranbaxy with Sun Pharma, to decide the issue within two days.Hearing appeals filed by Sun Pharmaceutical, Ranba...

FIPB to Take Up 34 FDI Proposals on Tuesday: Report

May 12, 2014 at 07:59 | Source: NDTV Profit

New Delhi: The Foreign Investment Promotion Board (FIPB) will take up 34 FDI proposals, including that of Ranbaxy Laboratories, Sistema Shyam and AT&T Global, on Tuesday. The other proposals which are before the board include those of Indian&...

FIPB to take up 34 FDI proposals on Tuesday

May 12, 2014 at 04:52 | Source: Economic Times

NEW DELHI: The Foreign Investment Promotion Board (FIPB) will take up 34 FDI proposals, including that of Ranbaxy Laboratories, Sistema Shyam and AT&T Global, on Tuesday. The other proposals which are before the board include those of Indian Rotocra...

Daiichi Files Plea in High Court to Vacate Stay on Sun-Ranbaxy Merger

May 11, 2014 at 16:00 | Source: NDTV Profit

Hyderabad: Daiichi Sankyo, owner of Ranbaxy Laboratories Limited, has filed a petition in Andhra Pradesh High Court requesting it to vacate the 'status quo' order it issued earlier on Sun Pharma-Ranbaxy merger process. The High Court ...

Minority Shareholders' Nod Not Needed for Sun Pharma Deal: Ranbaxy

May 09, 2014 at 23:59 | Source: NDTV Profit

New Delhi: Drug major Ranbaxy Laboratories on Friday said it does not require approval from minority shareholders to go ahead with its merger deal with Sun Pharmaceutical. "According to our understanding, this transaction requires 75 per cen...

Minority shareholders approval not needed for Sun deal: Ranbaxy

May 09, 2014 at 19:56 | Source: Economic Times

NEW DELHI: Drug major Ranbaxy Laboratories today said it does not require approval from minority shareholders to go ahead with merger deal with Sun Pharmaceutical. "According to our understanding, this transaction requires 75 per cent approval of all...

Sun Pharma comes under IT scanner

May 06, 2014 at 09:01 | Source: Economic Times

The income-tax department is investigating Sun Pharmaceuticals, the country's biggest drug maker, for some relatedparty transactions and alleged misuse of research & development expenses, three people familiar with the development told ET NOW. This c...

Sun Pharma under income tax department's scanner for 'misuse' of R D expenses

May 05, 2014 at 16:41 | Source: Economic Times

The income tax department is investigating Sun Pharmaceuticals, the country's biggest drug maker, for some related-party transactions and alleged misuse of research & development expenses, three people familiar with the development told ET NOW. This ...

Corporate earnings, FIIs to remain in focus this week: Experts

May 04, 2014 at 18:02 | Source: Business Today

With no major data due this week, stock market investors are expected to focus on the ongoing quarterly earnings and foreign fund inflows for further cues, analysts said.Major earning announcements this week are of companies such as HDFC, Lupin, Gle...

Corporate earnings, FIIs to remain in focus this week: Experts

May 04, 2014 at 11:31 | Source: Economic Times

NEW DELHI: With no major data due this week, stock market investors are expected to focus on the ongoing quarterly earnings and foreign fund inflows for further cues, analysts said. Major earning announcements this week are of companies such as HDFC...

HC blocks Ranbaxy-Sun Pharma merger over insider trading allegations

May 01, 2014 at 12:00 | Source: Money Rediff News Report

The Andhra Pradesh High Court on Tuesday put a stay on the proposed merger of Ranbaxy Laboratories with Sun Pharma, acting on a petition by a few individual investors alleging possible insider trading. HC blocks Ranbaxy-Sun Pharma merger over&nbs...

Sun Pharma, Ranbaxy deal hits fresh roadblock; stock slip 2% each

Apr 30, 2014 at 10:16 | Source: Economic Times

NEW DELHI: Shares of Sun Pharma and Ranbaxy Laboratories Ltd slipped over 2 per cent each in trade on Wednesday, after the Andhra Pradesh High Court has asked stock exchanges not to approve Sun Pharmaceutical's all-share transaction to buy Ranbaxy L...

Andhra Pradesh High Court puts on hold Sun-Ranbaxy deal till insider trade verdict

Apr 30, 2014 at 09:21 | Source: Economic Times

HYDERABAD: The Andhra Pradesh High Court has asked stock exchanges not to approve Sun Pharmaceutical's all-share transaction to buy Ranbaxy Laboratories until it decides on a petition alleging insider trading in the $4-billion (Rs 24,000-crore) deal....

video of the day

Positive on PSU banks; NPA cycle may have peaked: Barclays

Explore Moneycontrol

Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.